BNP Paribas Knock-Out ACS/ DE000PE9EXE3 /
21/06/2024 21:20:19 | Var.-0.050 | Denaro21:58:45 | Lettera21:58:45 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.660EUR | -7.04% | 0.660 Quantità in denaro: 5,000 |
0.690 Quantità in lettera: 5,000 |
ACS CONST. ACS,ACTIV... | 33.2959 EUR | 31/12/2078 | Call |
GlobeNewswire
17:06
ROSEN, THE FIRST FILING FIRM, Encourages AXT, Inc. Investors to Secure Counsel Before Important Dead...
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...